← back to search

Andrew R. Leach

LifeArc ·
Area of research
Computational Theory and Mathematics · Molecular Biology
Research interest
Research interests include Computational Drug Discovery Methods, Protein Structure and Dynamics, Bioinformatics and Genomic Networks, and Chemical Synthesis and Analysis.
h-index
44
citations
26,291
works
187
NIH funding
primary concept
Chemistry
email

Recent publications

Large-scale multi-omics identifies drug targets for heart failure with reduced and preserved ejection fraction
Nature Cardiovascular Research 2025cited by 13position: middledoi
Protein–ligand data at scale to support machine learning
Nature Reviews Chemistry 2025cited by 10position: middledoi
Leveraging Large-Scale Biobanks for Therapeutic Target Discovery
medRxiv 2025cited by 4position: middledoi
A data science roadmap for open science organizations engaged in early-stage drug discovery
Nature Communications 2024cited by 22position: middledoi
Genome-wide association analysis and Mendelian randomization proteomics identify drug targets for heart failure
Nature Communications 2023cited by 120position: middledoi
CACHE (Critical Assessment of Computational Hit-finding Experiments): A public–private partnership benchmarking initiative to enable the development of computational methods for hit-finding
Nature Reviews Chemistry 2022cited by 99position: middledoi
Actionable druggable genome-wide Mendelian randomization identifies repurposing opportunities for COVID-19
Nature Medicine 2021cited by 245position: middledoi
Target 2035 – update on the quest for a probe for every protein
RSC Medicinal Chemistry 2021cited by 79position: middledoi
The Global Phosphorylation Landscape of SARS-CoV-2 Infection
Cell 2020cited by 1,144position: middledoi
ChEMBL: towards direct deposition of bioassay data
Nucleic Acids Research 2018cited by 2,385position: lastdoi
Unexplored therapeutic opportunities in the human genome
Nature Reviews Drug Discovery 2018cited by 381position: middledoi
Erratum: Unexplored therapeutic opportunities in the human genome
Nature Reviews Drug Discovery 2018cited by 321position: middledoi
Drug Target Commons: A Community Effort to Build a Consensus Knowledge Base for Drug-Target Interactions
Cell chemical biology 2017cited by 170position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Anne Hersey · European Bioinformatics Institute2 papers (2017–2018)Kristina Edfeldt · Structural Genomics Consortium1 papers (2024–2024)Jon Chambers · European Bioinformatics Institute1 papers (2018–2018) · 1 papers (2024–2024)Dafydd R. Owen · Pfizer (United States)1 papers (2024–2024)Prudence Mutowo · European Bioinformatics Institute1 papers (2018–2018) · 1 papers (2017–2017)María Paula Magariños · European Bioinformatics Institute1 papers (2018–2018) · 1 papers (2017–2017)Anna Gaulton · Bioscientifica (United Kingdom)1 papers (2018–2018)Brinton Seashore‐Ludlow · Science for Life Laboratory1 papers (2017–2017) · 1 papers (2017–2017)Matthew Hartley · European Bioinformatics Institute1 papers (2024–2024) · 1 papers (2017–2017)Nicholas J. Skelton · Gene Therapy Laboratory1 papers (2024–2024)Aldo Segura‐Cabrera · European Bioinformatics Institute1 papers (2018–2018)Michał Nowotka · European Bioinformatics Institute1 papers (2018–2018)Susanne Müller · University of Stuttgart1 papers (2024–2024)Alok Jaiswal · Broad Institute1 papers (2017–2017)James Wellnitz · Purdue University West Lafayette1 papers (2024–2024)